AURX

$1.27+0.00%visit website

Nuo Therapeutics, Inc.

Market Cap

$62M

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Surgical & Medical Instruments & Apparatus

Beta (raw)

-594.28

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

11.8

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	1,032	1,097	1,302	1,769	5,200
Cost of revenue	407	408	452	599	1,867
Gross profit	625	688	850	1,170	3,333
Selling, general & administrative	1,166	1,268	1,296	1,337	5,066
Total operating expenses	1,166	1,268	1,296	1,337	5,066
Operating income	(540)	(579)	(446)	(167)	(1,732)
Net income	(538)	(578)	(618)	(278)	(2,012)
EPS (basic) ($)	(0.01)		(0.01)	(0.01)	(0.04)
Weighted avg. shares (basic)	47,539		48,285	48,408

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 59 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

6 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 6, 2026 accepted 8:57 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
Aug 17, 2026 accepted 11:55 AM ET	2.02Earnings release	Document SEC ↗
Jun 3, 2026 accepted 9:41 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
May 14, 2026 accepted 9:11 PM ET	2.02Earnings release	Document SEC ↗
Jan 26, 2026 accepted 9:25 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
Dec 17, 2025 accepted 4:09 PM ET	5.07Shareholder vote	Document SEC ↗
Oct 10, 2025 accepted 12:30 PM ET	5.02Officer / director change5.08Director nominations8.01Other events	Document SEC ↗
May 15, 2025 accepted 8:32 PM ET	1.01Material agreement	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

Aurora Innovation xStock Price, AURX Price, Live Charts, and Marketcap - Coinbase Australia

Coinbase · 2026-11-03

Aurora Innovation xStock Price | AURX Price Today, Live Chart, USD converter, Market Capitalization

CryptoRank · 2026-11-01

Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Yahoo Finance · 2026-08-17

QTEX Stock Price and Chart — NASDAQ:QTEX

TradingView · 2026-05-20

Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Yahoo Finance · 2026-05-14

Aurex Energy (TSXV:AURX) Stock Price, News & Quote

Investing News Network · 2023-04-13

Martin P Rosendale Net Worth (2026)

GuruFocus · 2023-04-10

LUCD Stock Price and Chart — NASDAQ:LUCD

TradingView · 2021-10-14

OM Stock Price and Chart — NASDAQ:OM

TradingView · 2020-09-16

AURX Stock Price and Chart — OTC:AURX

TradingView · 2017-07-22

Informational purposes only, not investment advice.

Corporate Events (8-K)

6 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 6, 2026 accepted 8:57 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
Aug 17, 2026 accepted 11:55 AM ET	2.02Earnings release	Document SEC ↗
Jun 3, 2026 accepted 9:41 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
May 14, 2026 accepted 9:11 PM ET	2.02Earnings release	Document SEC ↗
Jan 26, 2026 accepted 9:25 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
Dec 17, 2025 accepted 4:09 PM ET	5.07Shareholder vote	Document SEC ↗
Oct 10, 2025 accepted 12:30 PM ET	5.02Officer / director change5.08Director nominations8.01Other events	Document SEC ↗
May 15, 2025 accepted 8:32 PM ET	1.01Material agreement	Document SEC ↗

AURX

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Nuo Therapeutics, Inc. (AURX)

Factor Profile

Corporate Events (8-K)